Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel PK/PD study of ovulation inhibition across BMI categories
2019-001143-43Phase 4Terminated
- Sponsor
- Gedeon Richter Plc
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of avatrombopag, sponsored by Gedeon Richter Plc. Primary endpoint: Ovulatory suppression failure. Started Jun 2019; status: terminated.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on 2019-001143-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001143-43.